Home
About
Overview
Sharing Data
ORCID
Help
History (1)
The Role of GLP-1 Agonists in Mitigating Lorlatinib-Induced Metabolic Syndrome: Two Case Studies.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The Role of GLP-1 Agonists in Mitigating Lorlatinib-Induced Metabolic Syndrome: Two Case Studies.
The Role of GLP-1 Agonists in Mitigating Lorlatinib-Induced Metabolic Syndrome: Two Case Studies. Clin Lung Cancer. 2025 Jul; 26(5):429-433.
View in:
PubMed
authors with profiles
Silvana Pannain
Marina Chiara Garassino
Christine Bestvina